Annual Drug Patent Expirations for BELEODAQ
Beleodaq is a drug marketed by Acrotech and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for BELEODAQ.
This drug has fifty-two patent family members in twenty-seven countries.
The generic ingredient in BELEODAQ is belinostat. Additional details are available on the belinostat profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
